Geneva, Switzerland – [05/12/2025] – EarlySight SA (“EarlySight”), a Swiss medtech company pioneering cellular-level retinal imaging and biomarkers, is pleased to announce a strategic collaboration
We’re thrilled to announce the extension of our Seed round to 𝐂𝐇𝐅 6.1 𝐦𝐢𝐥𝐥𝐢𝐨𝐧, with Zürcher Kantonalbank joining our investor syndicate alongside Verve Ventures, Nina Capital,
Checkout our latest product overview video accessible here: https://youtu.be/-HCs6JhUos0 At EarlySight, we are dedicated to revolutionizing the field of ophthalmology through cutting-edge technology and innovative
EarlySight is thrilled to announce the appointment of Jérôme Martinez as an independent board member. With his deep expertise and proven leadership in the pharmaceutical,
We’re proud to share that 𝐄𝐚𝐫𝐥𝐲𝐒𝐢𝐠𝐡𝐭 has been ranked among the 𝐓𝐨𝐩 100 𝐒𝐰𝐢𝐬𝐬 𝐒𝐭𝐚𝐫𝐭-𝐮𝐩𝐬 𝐨𝐟 2024, placing 6𝐭𝐡 𝐢𝐧 𝐭𝐡𝐞 𝐌𝐞𝐝𝐓𝐞𝐜𝐡 𝐜𝐚𝐭𝐞𝐠𝐨𝐫𝐲 and 48𝐭𝐡 𝐨𝐯𝐞𝐫𝐚𝐥𝐥! 🎉 🔍 𝐖𝐡𝐲
Govindahari, V., Dornier, R., Ferdowsi, S. et al., 2024 High-resolution adaptive optics-trans-scleral flood illumination (AO-TFI) imaging of retinal pigment epithelium (RPE) in central serous chorioretinopathy
EarlySight will be attending the Association for Research in Vision and Ophthalmology (ARVO) congress 2024 (booth #1332) which will take place in the Seattle Convention Center – Arch
We are delighted to share that EarlySight was awarded the Innosuisse certificate, which indicates the readiness for sustainable growth of our company after completion of
EarlySight will be attending the 23rd EURETINA Congress, booth #12.612 which will take place in the RAI Amsterdam, The Netherlands from 5 – 8 October
Thomas Ibanez is joining EarlySight as Software engineer. With a Master of Science degree in Computer Science from EPFL, he brings a diversity of expertise
ARVO annual meeting is around the corner. EarlySight will unveil its Adaptive Optics retinal camera for imaging the retinal pigment epithelium, photoreceptors, and retinal nerve
KOWALCZUK, Laura, DORNIER, Rémy, KUNZI, Mathieu, et al.In Vivo Retinal Pigment Epithelium Imaging using Transscleral Optical Imaging in Healthy Eyes. Ophthalmology Science, 2023, vol. 3,
Honoured to be selected in the Top100 Swiss Startup Award by Venturelab for the second consecutive year! It is a great recognition for the amazing
We are proud to present Cellularis® Discovery, a revolutionary ophthalmic camera, at Euretina Congress Hamburg on 1-4 September 2022. Visit us at booth H32 to
We are happy to share the following news related to the use of our novel imaging technology: Four posters discussing the use of adaptive optics
EarlySight announces the certification of its quality management system by BSI group according to ISO 13485 standard. This certification constitutes a mark of trust and
Caetano dos Santos, F.L., Laforest, T., Künzi, M. et al. Fully automated detection, segmentation, and analysis of in vivo RPE single cells. Eye 35, 1473–1481
EarlySight granted a breakthrough patent for its unique eye imaging method for ophthalmology EarlySight has been granted a patent by the United States Patent and
EarlySight is proud to be selected 84th in the TOP 100 Swiss Startup for the year 2021. It is a big honor to be among
We are very excited to announce that Sonja Simon-Zoula joins the team as Head of Clinical Operations. Sonja is a clinical expert with more than 18
We are very pleased to be joined by Benedetto Sgroi as Global Head of Business Development, Sales and Marketing. Benedetto is a seasoned Entrepreneur, Board Member,
EarlySight is delighted to announce today the first closing of CHF 2.3 million out of a CHF 3 million seed funding round. The start-up, which
Laforest, T., Künzi, M., Kowalczuk, L. et al. Transscleral optical phase imaging of the human retina. Nat. Photonics 14, 439–445 (2020). https://doi.org/10.1038/s41566-020-0608-y View at publisher
